Global Ganja Report

Hemp Business Journal reports that products infused with CBD oil are leading growth in hermp-derived products sold in the United States generally, which in 2016 had a collective retail value of $688 million. This figure represents a five year 22% compound annual growth rate (CAGR). Joining more traditional products such as shelled seed, protein powder, soaps and lotions, are growing lines of medicinal preparations such as CBD edibles. Hemp-derived cannabidiol (CBD) accounted for $130 million in sales last year.

Oops, he did it again. Acting Drug Enforcement Administration chief Chuck Rosenberg reiterated his oft-voiced opinion on May 25 that "marijuana is not medicine." The Washington Examiner reports that he told an audience at a clinic in Cleveland: "If it turns out that there is something in smoked marijuana that helps people, that's awesome. I will be the last person to stand in the way of that... But let's run it through the Food and Drug Administration process, and let's stick to the science on it."

Guy Philippe, a former paramilitary boss and coup leader who was elected to Haiti's Senate in November, was arrested by the DEA on Jan. 5—just days before he would have been sworn into office and obtained immunity. Philippe had been wanted by the US since 2005 on charges of conspiracy to import cocaine and money laundering.

After a high-profile but very quick trial in a US federal court in Manhattan, two young scions of Venezuela's First Family were convicted on Nov. 19 of conspiring to traffick more than 800 kilograms of cocaine into the United States. The two men, Efraín Antonio Campo Flores and Francisco Flores de Freitas, are nephews of Cilia Flores—wife of Venezuela's embattled President Nicolás Maduro. The case came amid massive anti-government protests in Venezuela, and Cilia Flores charged that her nephews had been "kidnapped" by the DEA for political reasons. Popped just over a year ago in Haiti, they now face a maximum sentence of life in prison.

A little New York-California cross-fertilization of herbal consciousness took place as Martin Lee, the author of Smoke Signals: A Social History of Marijuana, spoke in Manhattan's East Village the night of Nov. 10 on "The Future of CBD and Medicinal Cannabis." Lee discussed his current work with California-based Project CBD, dedicated to promoting and publicizing research into the medical uses of cannabidiol, and Emerald Pharms, his CBD-oriented dispensary in Hopland, southern Medocino County. The event was hosted by The Alchemist's Kitchen, a New Age-flavored herbal apothecary—or "botanical dispensary"—on East 1st Street. Under New York state's medical marijuana law, the Kitchen recently launched a Bowery Cannabis Club, which specializes in CBD products.

With Venezuela deep in political crisis, the trial opened in US district court in Manhattan this week of two scions of the country's First Family charged with cocaine trafficking. The two men, Efraín Antonio Campo Flores and Francisco Flores de Freitas, are nephews of Cilia Flores—wife of embattled President Nicolás Maduro. In opening statements, Assistant US Attorney Emil Bove said the pair were secretly recorded planning to ship 800 kilos of coke from Venezuela to Honduras for re-export to the United States.

Last month, when the DEA dashed activist hopes for a rescheduling of cannabis, it also issued another lesser-noted decision—to put the psychoactive herb kratom in the same Schedule I classification as pot, that for the most dangerous drugs with no medical use. Advocates have launched a White House petition against the kratom ban, and have already won the required 100,000 signatures to trigger an administration reponse. The DEA decision takes effect on Sept. 30, while the White House has 60 days to respond to the petition, under its own policy.

After much speculation that the US Drug Enforcement Agency (DEA) would reschedule cannabis this summer, the agency on Aug. 11 dashed petitioners' hopes, rejecting their request to remove its classification as a Schedule I dangerous drug. The DEA denied two separate requests by former state governors to re-classify cannabis as a Schedule II drug or lower. The agency stated (PDF) that the Department of Health and Human Services (HHS) has "concluded that marijuana has high potential for abuse, has no accepted medical use in the United States, and lacks an acceptable level of safety for use even under medical supervision." Tthe DEA did propose a new policy that would allow universities to apply to grow cannabis for research. Until now, the University of Mississippi had a monopoly on cultivation for study. (Jurist)